Effect of Cigarette Smoking on Sputum Smear Conversion Time Among Adult New Pulmonary Tuberculosis Patients: A Study from Iran Southeast

Authors

Maliheh Metanat1, Batool Sharifi Mood1,*, Mina Parsi1, Sara Sanei Moghaddam1
1Research Center for Infectious Diseases and Tropical Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
*Corresponding Author: Research Center for Infectious Diseases and Tropical Medicine, Boo-Ali Hospital, Zahedan, IR Iran., [email protected]. Email: [email protected]

Archives of Clinical Infectious Diseases:Vol. 5, issue 1; 14-7
Published online:Jan 31, 2010
Article type:Research Article
How to Cite:Metanat M, Sharifi Mood B, Parsi M, Sanei Moghaddam S. Effect of Cigarette Smoking on Sputum Smear Conversion Time Among Adult New Pulmonary Tuberculosis Patients: A Study from Iran Southeast. Arch Clin Infect Dis. 2010;5(1):. doi:

Abstract

Background:

Cigarettes smoking is a risk factor for tuberculosis (TB). Associations between smoking and TB disease have been reported, but there are few reports on the influence of smoking on the sputum smear and culture conversion time. This study surveyed the possible association between smoking and sputum smear conversion time among new smear-positive pulmonary tuberculosis patients.

Patients and methods:

Between May 2005 and December 2006, we evaluated smokers and non-smokers patients with pulmonary TB referred to Zahedan Tuberculosis Center (Southeastern Iran). Patients were not immunosuppressed or infected by human immunodeficiency virus (HIV). Drug resistant cases were also excluded.

Results:

A total of 200 TB patients, including 100 smokers, were evaluated. There was a significant delay in sputum smear conversion time between smokers and non-smokers 2 (53% vs. 10%, respectively, p<0.001) and 3 months following the treatment (19% vs. 2%, respectively, p<0.001). However, there was no significant difference in failure rate (a positive smear at the end of the 5th month of treatment) between two groups (95% vs. 97%).

Conclusion:

Our results revealed that smoking is significantly associated with a delay in sputum smear conversion time, hence, pulmonary TB cases must be strongly encouraged to cease smoking.

Full Text

Full text is available in PDF

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jul
2009

Association Between Cigarette Smoking and Pulmonary Tuberculosis in Men: A Case-Control Study in Mazandaran, Iran

Roya Ghasemian,
Narges Najafi,
Davood Yadegarinia,
Shahriar Alian

Ghasemian R, Najafi N, Yadegarinia D, Alian S. Association Between Cigarette Smoking and Pulmonary Tuberculosis in Men: A Case-Control Study in Mazandaran, Iran. Arch Clin Infect Dis. 2009;4(3):. doi:

25
Jul
2012

Association Between Tuberculosis and Smoking

Roya Alavi-Naini,
Batool Sharifi-Mood,
Maliheh Metanat

Alavi-Naini R, Sharifi-Mood B, Metanat M. Association Between Tuberculosis and Smoking. Int J High Risk Behav Addict. 2012;1(2):71-74. doi: https://doi.org/10.5812/ijhrba.5215

23
Sep
2014

Comparison of Chest X-Ray Findings of Smear Positive and Smear Negative Patients with Pulmonary Tuberculosis

Azadeh Ebrahimzadeh,
Mahyar Mohammadifard,
Godratallah Naseh

Ebrahimzadeh A, Mohammadifard M, Naseh G. Comparison of Chest X-Ray Findings of Smear Positive and Smear Negative Patients with Pulmonary Tuberculosis. I J Radiol. 2014;11(4):e13575. doi: https://doi.org/10.5812/iranjradiol.13575

31
Jul
2017
The Follow-up of 360 Patients with Pulmonary Tuberculosis After 2 Months Treatment With Anti-tubercular Agents in Iran

The Follow-up of 360 Patients with Pulmonary Tuberculosis After 2 Months Treatment With Anti-tubercular Agents in Iran

Marzieh Kazerani,
Maryam Kazerani,
Kiarash Ashrafzadeh,
Shamim Rahiman,
Mahdi Mottaghy,
Amin Samihi

Kazerani M, Kazerani M, Ashrafzadeh K, Rahiman S, Mottaghy M, et al. The Follow-up of 360 Patients with Pulmonary Tuberculosis After 2 Months Treatment With Anti-tubercular Agents in Iran. Arch Clin Infect Dis. 2018;13(4):e62132. doi: https://doi.org/10.5812/archcid.62132

2
Mar
2013

Seroprevalence of HIV in Newly Detected Pulmonary Tuberculosis Patients in Khuzestan, Iran: Should HIV Testing Be Included in National Tuberculosis Program in This Region?

Seyed Mohammad Alavi,
Hamid Moradzadegan,
Mohammad Mehdi Khoshkhoy

Alavi SM, Moradzadegan H, Khoshkhoy MM. Seroprevalence of HIV in Newly Detected Pulmonary Tuberculosis Patients in Khuzestan, Iran: Should HIV Testing Be Included in National Tuberculosis Program in This Region?. Jundishapur J Microbiol. 2013;6(2):193-196. doi: https://doi.org/10.5812/jjm.5222

More by these authors

Maliheh MetanatPubMedScholar
Batool Sharifi MoodPubMedScholar
Mina ParsiPubMedScholar
Sara Sanei MoghaddamPubMedScholar
Share
Cited by
Metrics